We advise that Potiga use be limited to patients who have not responded adequately to several alternative therapies to decrease the frequency of seizures, or epilepsy, and for whom the benefits of treatment outweigh the risks. -FDA
Toledo, OH (PRWEB) November 07, 2013
Zoll, Kranz & Borgess, LLC has just announced that they are offering free case evaluations for individuals who have taken the Potiga and have experienced specific side-effects.
The U.S. Food and Drug Administration released a safety announcement recently that the drug, Potiga, has a new black box warning which is their highest warning they give. Potiga is currently used to prevent seizures but the risks might be too high and an alternative should be discussed.
Before taking Potiga one should get their eyes checked and see an ophthalmic professional. If a patient cannot have their vision checked during treatment it is advised they should not take Potiga.
Patients that are currently taking Potiga should consult with their health care professionals to ensure that they should continue with this drug and that the benefits of treatment outweighs the risks.
Another component of the updated label is the warning of the skin, nail, mucous, membrane, and white-of-the-eye discoloration. The recommendation from the FDA is to seek an alternative medication if the previously stated does occur.
ZKB Law has worked on behalf of individuals and their families affected by dangerous medications since 1988. Individuals who have taken the drug and experienced the listed symptoms may have a potential case. If you have taken, or are currently taking Potiga you should call ZKB toll free at (888) 841-9623 for your free case evaluation. If you have questions or concerns contact an attorney at Zoll, Kranz & Borgess, LLC.